| 2022-11-03 | +19.2% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-05-08 | +17.0% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2023-11-02 | +15.2% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2021-05-06 | -13.0% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2022-05-05 | -12.6% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2022-05-06 | -11.8% | legal | SEC EDGAR | PODD 8-K: 5.02, 8.01 (SEC Filing) |
| 2023-08-08 | -10.8% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2023-08-08 | -10.8% | legal | SEC EDGAR | PODD 8-K: 8.01 and (SEC Filing) |
| 2024-11-07 | +10.8% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-08-07 | +10.1% | earnings | Seeking Alpha | Insulet raises full-year 2025 revenue growth guidance to 24%-27% as Omnipod 5 drives global adoption |
| 2025-08-07 | +10.1% | earnings | Seeking Alpha | Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript |
| 2025-08-07 | +10.1% | earnings | Seeking Alpha | Insulin pump makers Tandem and Insulet post contrasting Q2 results |
| 2025-08-07 | +10.1% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2022-02-24 | +9.9% | legal | SEC EDGAR | PODD 8-K: 5.02, 5.03 (SEC Filing) |
| 2022-02-23 | +9.2% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2021-05-05 | -7.7% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-10-03 | -7.2% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-08-08 | -7.1% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | -6.7% | earnings | Seeking Alpha | Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations |
| 2026-02-19 | -6.7% | analyst | Investing.com | Bernstein cuts Insulet stock price target on competition concerns - Investing.com |
| 2026-02-19 | -6.7% | earnings | Seeking Alpha | Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations (NASDAQ:PODD) - Seeking Alpha |
| 2024-02-22 | -6.4% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2024-05-09 | -6.2% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -5.9% | news | Stock Titan | Insulet finds Omnipod 5 pod issue tied to 18 serious high-blood-sugar events - Stock Titan |
| 2026-01-09 | -5.7% | news | Stock Titan | Maker of tubeless insulin pumps sets date to share 2025 results - Stock Titan |
| 2026-02-17 | +5.6% | news | ChartMill | Insulet Corp (NASDAQ:PODD): A Prime GARP Candidate in Diabetes Care - ChartMill |
| 2025-11-21 | +5.4% | analyst | Seeking Alpha | Insulet Corporation (PODD) Analyst/Investor Day Transcript |
| 2025-12-01 | -5.3% | news | MarketWatch | Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch |
| 2026-03-13 | -5.3% | news | Seeking Alpha | Insulet Corporation (PODD) Discusses Omnipod 5 Manufacturing Issue and Medical Device Recall at ATTD Conference Transcript |
| 2026-03-13 | -5.3% | news | Seeking Alpha | Insulet recalling certain defective Omnipod insulin delivery devices |
| 2026-03-13 | -5.3% | news | GuruFocus | Insulet (PODD) Faces Stock Dip After Voluntary Device Correction - GuruFocus |
| 2026-03-13 | -5.3% | news | MarketWatch | Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch |
| 2026-03-13 | -5.3% | news | CNBC | Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a Farm & more - CNBC |
| 2026-03-13 | -5.3% | news | Quiver Quantitative | Insulet falls as Omnipod 5 Pod medical device correction spotlights manufacturing issue - Quiver Quantitative |
| 2026-01-27 | -5.2% | analyst | Investing.com | Cowen assumes coverage on Insulet stock with Hold rating - Investing.com |
| 2025-09-16 | -5.0% | earnings | Seeking Alpha | Insulet taps new CFO; expects to top Q3 revenue growth outlook |
| 2025-09-16 | -5.0% | legal | SEC EDGAR | PODD 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-11-19 | -5.0% | analyst | Seeking Alpha | Insulet upgraded at UBS ahead of analyst day on growth prospects |
| 2025-06-09 | -4.8% | legal | SEC EDGAR | PODD 8-K: 1.01, 1.02, 2.03, 8.01 (SEC Filing) |
| 2026-04-20 | -4.7% | news | Yahoo Finance | Is Insulet Corporation (PODD) One of the Most Oversold Healthcare Stocks to Invest In? - Yahoo Finance |
| 2026-04-20 | -4.7% | news | DirectorsTalk Interviews | Insulet Corporation (PODD) Stock Analysis: A 63.6% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews |
| 2023-02-24 | -4.5% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-08-14 | +4.3% | earnings | Seeking Alpha | Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold |
| 2025-04-28 | -4.3% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-31 | -4.1% | earnings | MarketBeat | Insulet (NASDAQ:PODD) Reaches New 12-Month Low - Time to Sell? - MarketBeat |
| 2026-04-21 | -4.0% | news | GlobeNewswire | Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed |
| 2026-04-21 | -4.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Insulet Corporation (PODD) stock worth including in a portfolio (Bearish Sentiment) 2026-04-20 - Social Trading Insights - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-09-09 | -3.9% | news | Seeking Alpha | Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript |
| 2025-10-23 | -3.9% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-09 | -3.9% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2025-11-20 | -3.8% | news | Seeking Alpha | Insulet drops on investor day as long-term outlook unveiled |
| 2025-11-20 | -3.8% | earnings | Stock Titan | Insulet (NASDAQ: PODD) projects 25%+ EPS CAGR and details 2025–2028 growth, AID pipeline - Stock Titan |
| 2025-11-20 | -3.8% | news | Investing.com | Insulet stock drops amid market weakness despite strong long-term outlook - Investing.com |
| 2025-11-20 | -3.8% | news | Seeking Alpha | Insulet stock drops on investor day (PODD:NASDAQ) - Seeking Alpha |
| 2025-11-20 | -3.8% | news | GuruFocus | Insulet (PODD) Shares Fall Amid Ambitious Growth Plans Unveiled - GuruFocus |
| 2026-04-09 | -3.7% | analyst | Yahoo Finance | Analysts See 75% Upside on Insulet Corporation (PODD) Despite Weak Share Price Momentum - Yahoo Finance |
| 2026-04-09 | -3.7% | news | MarketWatch | Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-01-12 | -3.7% | analyst | Investing.com | Barclays downgrades Insulet stock rating to Underweight on competition concerns - Investing.com |
| 2024-03-20 | -3.6% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-11-12 | +3.6% | news | Yahoo Finance | Zacks.com featured highlights include Insulet, Celestica and Innodata - Yahoo Finance |
| 2026-03-16 | +3.6% | news | TIKR.com | Insulet Stock Drops 7% After Omnipod 5 Recall - TIKR.com |
| 2026-03-16 | +3.6% | analyst | MarketWatch | Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-04-01 | -3.5% | earnings | Seeking Alpha | Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags |
| 2026-04-01 | -3.5% | earnings | Stock Titan | Insulet sets May 6 earnings release, 8 a.m. conference call - Stock Titan |
| 2026-04-01 | -3.5% | earnings | MarketBeat | 7,473 Shares in Insulet Corporation $PODD Acquired by J. Safra Sarasin Holding AG - MarketBeat |
| 2026-04-01 | -3.5% | news | MarketWatch | Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch |
| 2024-01-25 | -3.3% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-11-24 | -3.1% | news | Yahoo Finance | Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice - Yahoo Finance |
| 2022-12-01 | +3.1% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-02-23 | +2.8% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2026-01-05 | +2.8% | news | Yahoo Finance | Declining Stock and Solid Fundamentals: Is The Market Wrong About Insulet Corporation (NASDAQ:PODD)? - Yahoo Finance |
| 2024-05-20 | -2.8% | legal | SEC EDGAR | PODD 8-K: 1.01 and (SEC Filing) |
| 2025-11-06 | +2.7% | earnings | Seeking Alpha | Insulet Corporation 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-06 | +2.7% | earnings | Seeking Alpha | Insulet raises full-year Omnipod revenue growth guidance to 29–30% as international momentum accelerates |
| 2025-11-06 | +2.7% | earnings | Seeking Alpha | Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript |
| 2025-11-06 | +2.7% | earnings | Seeking Alpha | Insulet Non-GAAP EPS of $1.24 beats by $0.09, revenue of $706.3M beats by $27.29M |
| 2025-11-06 | +2.7% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +2.7% | earnings | Yahoo Finance | Insulet (PODD) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance |
| 2022-07-11 | -2.6% | legal | SEC EDGAR | PODD 8-K: 8.01 (SEC Filing) |
| 2022-08-04 | +2.6% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2026-03-27 | -2.6% | news | Stock Titan | Vanguard (PODD) parent reports 0 shares after realignment; subsidiaries to report - Stock Titan |
| 2026-04-07 | -2.6% | news | Investing.com | Insulet Corporation stock hits 52-week low at 199.53 USD - Investing.com |
| 2026-04-23 | -2.5% | earnings | Trefis | Why BSX Stock's Q1 Beat Is A Lagging Indicator |
| 2026-04-23 | -2.5% | earnings | Barchart | Insulet Corporation Earnings Preview: What to Expect |
| 2026-04-23 | -2.5% | news | GlobeNewswire | Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) |
| 2026-04-23 | -2.5% | news | ChartMill | PODD Stock Price, Quote & Chart | INSULET CORP (NASDAQ:PODD) - ChartMill |
| 2025-03-17 | +2.3% | legal | SEC EDGAR | PODD 8-K: 5.02 (SEC Filing) |
| 2026-04-02 | -2.3% | news | Stock Titan | Insulet Corp (PODD) EVP receives new stock options and RSU awards - Stock Titan |
| 2026-04-02 | -2.3% | news | Stock Titan | Insulet (PODD) board member elects 111 deferred stock units as fees - Stock Titan |
| 2026-04-02 | -2.3% | news | Stock Titan | INSULET CORP (PODD) EVP and CCO Michael Panos reports 5-share stake - Stock Titan |
| 2026-04-02 | -2.3% | analyst | MarketWatch | Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch |
| 2026-02-25 | +2.3% | news | ChartMill | Insulet Corp (NASDAQ:PODD): A High-Growth Stock Forming a Technical Base - ChartMill |
| 2026-01-13 | +2.2% | news | Seeking Alpha | Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-13 | +2.2% | news | Seeking Alpha | Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2023-06-12 | -2.1% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-08-05 | -2.1% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2021-11-04 | -2.1% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2026-03-25 | -2.0% | legal | PR Newswire | PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky - PR Newswire |
| 2026-03-25 | -2.0% | news | Investing.com | Insulet Corporation stock hits 52-week low at $216.12 - Investing.com |
| 2026-03-25 | -2.0% | news | MarketWatch | Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch |
| 2022-03-01 | +2.0% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2026-02-27 | -2.0% | news | Seeking Alpha | Insulet: The Growth Doesn't Stop Here |
| 2024-08-05 | +2.0% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-12-15 | -1.9% | legal | Seeking Alpha | FDA making use of real-world evidence in device applications easier |
| 2022-06-16 | +1.8% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-02-20 | +1.8% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-12-17 | +1.8% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2026-03-30 | -1.8% | analyst | Yahoo Finance | Truist Maintains Insulet Corporation (PODD) Buy Rating Despite Device Correction Announcement - Yahoo Finance |
| 2026-03-30 | -1.8% | news | Stock Titan | Diabetes tech maker Insulet taps Stryker veteran to lead global sales - Stock Titan |
| 2026-03-30 | -1.8% | earnings | MarketBeat | SG Americas Securities LLC Purchases 36,570 Shares of Insulet Corporation $PODD - MarketBeat |
| 2025-03-21 | +1.7% | legal | SEC EDGAR | PODD 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2023-06-07 | -1.7% | legal | SEC EDGAR | PODD 8-K: 1.01 and (SEC Filing) |
| 2026-04-10 | -1.7% | news | MarketWatch | Insulet Corp. stock falls to new 52-week low - MarketWatch |
| 2025-11-05 | +1.7% | earnings | Seeking Alpha | Insulet Q3 2025 Earnings Preview |
| 2026-02-23 | +1.7% | news | Yahoo Finance | O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD) - Yahoo Finance |
| 2026-02-23 | +1.7% | executive | Investing.com | Insulet (PODD) CEO McEvoy buys $1.03 million in shares - Investing.com |
| 2026-02-23 | +1.7% | earnings | DirectorsTalk Interviews | Insulet Corporation (PODD) Stock Analysis: A 46.51% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews |
| 2025-12-02 | -1.6% | news | Seeking Alpha | Insulet: Excellent Business, Valuation Hurdle Remains |
| 2025-12-02 | -1.6% | news | Seeking Alpha | Insulet Corporation: Excellent Business, Valuation Hurdle Remains (PODD) - Seeking Alpha |
| 2024-03-01 | +1.5% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2026-02-04 | -1.5% | news | ChartMill | Insulet Corp (NASDAQ:PODD) Matches Key Growth Rules in Navellier's "Little Book" Strategy - ChartMill |
| 2023-02-22 | +1.5% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2022-12-14 | -1.4% | legal | SEC EDGAR | PODD 8-K: 5.02 (SEC Filing) |
| 2026-02-16 | +1.3% | earnings | TradingView | Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow - TradingView |
| 2026-02-15 | +1.3% | expansion | Yahoo Finance | Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update - Yahoo Finance |
| 2026-04-17 | -1.3% | earnings | MarketBeat | Short Interest in Insulet Corporation (NASDAQ:PODD) Rises By 19.3% - MarketBeat |
| 2026-04-17 | -1.3% | news | MarketWatch | Insulet Corp. stock rises Friday, still underperforms market - MarketWatch |
| 2026-04-17 | -1.3% | news | Insider Monkey | Citi Flags Competitive Pressure as Key Risk for Insulet Corporation (PODD) - Insider Monkey |
| 2023-05-04 | +1.3% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-05-04 | +1.3% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-12-04 | -1.3% | analyst | Investing.com | Insulet stock price target maintained at $379 by TD Cowen on FDA clearance - Investing.com |
| 2021-10-18 | -1.3% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-12-04 | -1.2% | legal | SEC EDGAR | PODD 8-K: 8.01 and (SEC Filing) |
| 2022-02-07 | +1.2% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-19 | -1.2% | earnings | MarketBeat | Moran Wealth Management LLC Takes $5.19 Million Position in Insulet Corporation $PODD - MarketBeat |
| 2026-01-02 | -1.1% | news | Yahoo Finance | Is it the Right Time to Add Insulet Stock to Your Portfolio? - Yahoo Finance |
| 2026-03-21 | -1.1% | news | Yahoo Finance | Is Insulet Stock Underperforming the Dow? - Yahoo Finance |
| 2025-03-10 | +0.9% | legal | SEC EDGAR | PODD 8-K: 1.01 and (SEC Filing) |
| 2025-09-04 | +0.9% | news | Seeking Alpha | Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet outlines 21%–23% Omnipod revenue growth for 2026 with operating margin expansion, driven by global adoption and product innovation |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet gains after Q4 print as outlook tops consensus |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet Corporation 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet Non-GAAP EPS of $1.55 beats by $0.09, revenue of $783.8M beats by $15.07M |
| 2026-02-18 | +0.9% | legal | SEC EDGAR | PODD 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-18 | +0.9% | earnings | Drug Delivery Business | Insulet stock rises before hours on Street-beating Q4, 31% sales growth - Drug Delivery Business |
| 2026-02-18 | +0.9% | news | Yahoo Finance | Insulet (PODD) Shares Skyrocket, What You Need To Know - Yahoo Finance |
| 2026-02-18 | +0.9% | analyst | Yahoo Finance | What Are Wall Street Analysts' Target Price for Insulet Stock? - Yahoo Finance |
| 2026-02-18 | +0.9% | news | Finviz | Insulet (PODD) Shares Skyrocket, What You Need To Know - Finviz |
| 2026-02-18 | +0.9% | earnings | Seeking Alpha | Insulet stock gains on Q4 2025 print, outlook (PODD:NASDAQ) - Seeking Alpha |
| 2026-02-18 | +0.9% | earnings | Investing.com | Earnings call transcript: Insulet’s Q4 2025 revenue beats forecast, stock surges - Investing.com |
| 2026-02-18 | +0.9% | news | TradingView | Insulet (PODD) Shares Skyrocket, What You Need To Know - TradingView |
| 2026-02-18 | +0.9% | earnings | TradingView | Insulet (NASDAQ:PODD) Surprises With Q4 CY2025 Sales - TradingView |
| 2026-04-04 | -0.9% | earnings | MarketBeat | Aberdeen Group plc Has $64.08 Million Stock Position in Insulet Corporation $PODD - MarketBeat |
| 2026-03-03 | -0.9% | news | Stock Titan | Insulet (PODD) executive records Form 4 tax-withholding share dispositions - Stock Titan |
| 2026-03-03 | -0.9% | news | Stock Titan | Insulet (PODD) SVP uses 253 shares to cover RSU tax withholding - Stock Titan |
| 2021-10-04 | +0.9% | legal | SEC EDGAR | PODD 8-K: 8.01 (SEC Filing) |
| 2026-04-16 | -0.8% | news | PR Newswire | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD - PR Newswire |
| 2021-06-15 | -0.8% | legal | SEC EDGAR | PODD 8-K: 3.02 (SEC Filing) |
| 2026-02-03 | -0.8% | legal | SEC EDGAR | PODD 8-K: 1.01 and (SEC Filing) |
| 2026-03-11 | +0.7% | news | Stock Titan | Fully automated insulin system hits 68% time in range in type 2 study - Stock Titan |
| 2026-04-22 | -0.7% | news | GuruFocus | A Look at Insulet Corp (PODD) After 4.2% Decline -- GF Value $38 - GuruFocus |
| 2024-07-26 | -0.7% | legal | SEC EDGAR | PODD 8-K: 2.02 and (SEC Filing) |
| 2025-05-28 | -0.7% | legal | SEC EDGAR | PODD 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-02-14 | -0.6% | legal | SEC EDGAR | PODD 8-K: 1.01 and (SEC Filing) |
| 2026-03-04 | -0.5% | legal | SEC EDGAR | PODD 8-K: 5.02 (SEC Filing) |
| 2026-03-04 | -0.5% | M&A | Stock Titan | Former Insulet (NASDAQ: PODD) CFO Ana Chadwick signs severance deal - Stock Titan |
| 2025-11-04 | -0.5% | earnings | Yahoo Finance | Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance |
| 2025-02-21 | +0.5% | legal | SEC EDGAR | PODD 8-K: 5.02 and (SEC Filing) |
| 2025-11-22 | +0.4% | analyst | TIKR.com | Insulet Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com |
| 2025-11-13 | +0.4% | earnings | Yahoo Finance | Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand - Yahoo Finance |
| 2026-02-26 | +0.4% | analyst | Yahoo Finance | Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating - Yahoo Finance |
| 2026-02-26 | +0.4% | news | Seeking Alpha | Insulet: The Growth Doesn't Stop Here - Seeking Alpha |
| 2026-02-26 | +0.4% | news | Investing.com Nigeria | Insuleet (PODD) director Minogue buys $499,846 in shares By Investing.com - Investing.com Nigeria |
| 2026-01-30 | +0.4% | news | Yahoo Finance | Reasons Why Hedge Funds Favor Insulet Corp (PODD) - Yahoo Finance |
| 2024-01-18 | -0.4% | legal | SEC EDGAR | PODD 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-14 | +0.4% | analyst | Yahoo Finance | Evercore Reiterates Outperform Rating for Insulet Corp. (PODD) - Yahoo Finance |
| 2026-04-14 | +0.4% | analyst | MarketWatch | Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch |
| 2025-08-25 | +0.3% | executive | Seeking Alpha | Insulet appoints new COO |
| 2026-03-06 | +0.2% | news | MarketWatch | Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch |
| 2021-05-14 | -0.2% | legal | SEC EDGAR | PODD 8-K: 3.02 (SEC Filing) |
| 2026-03-26 | -0.1% | legal | GlobeNewswire | PODD Investor Alert: Insulet Corp. Potential Securities - GlobeNewswire |
| 2026-04-13 | +0.1% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Insulet Corporation (PODD) Stock in a Selling Zone | Price at $197.60, Up 0.34% - Shared Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-13 | +0.1% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Insulet Corporation (PODD) Stock in a Selling Zone | Price at $197.60, Up 0.34% - Trending Social Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-09-06 | +0.1% | earnings | simplywall.st | Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher - simplywall.st |
| 2025-09-17 | +0.1% | news | Yahoo Finance | Why Insulet (PODD) Shares Are Falling Today - Yahoo Finance |
| 2026-03-20 | -0.0% | earnings | Yahoo Finance | Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance |
| 2026-03-20 | -0.0% | news | TradingView | Should You Continue to Hold Insulet Stock in Your Portfolio? - TradingView |
| 2026-04-27 | — | news | Benzinga | Jim Cramer Has A Clear Take On Rivian's Future — And A Warning About An AI Name |
| 2026-04-26 | — | news | Simply Wall St. | How The Insulet (PODD) Narrative Is Shifting After Omnipod 5 Correction And Repriced Expectations |
| 2026-04-26 | — | news | Insider Monkey | Jim Cramer on Insulet Corporation: “It’s Still Too Expensive Because of the GLP-1 Threat” |
| 2026-04-26 | — | news | Insider Monkey | Jim Cramer on Insulet Corporation: “It’s Still Too Expensive Because of the GLP-1 Threat” - Insider Monkey |
| 2026-04-26 | — | news | HarianBasis.co | Insulet Stock Analysis and Market Decline - HarianBasis.co |
| 2026-04-25 | — | earnings | MarketBeat | Teacher Retirement System of Texas Reduces Stock Position in Insulet Corporation $PODD - MarketBeat |
| 2026-04-25 | — | analyst | Sahm | This Insulet Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Sahm |
| 2026-04-25 | — | earnings | MarketBeat | Insulet (NASDAQ:PODD) Rating Lowered to "Hold" at Rothschild & Co Redburn - MarketBeat |
| 2026-04-25 | — | news | Insider Monkey | Jim Cramer Highlighted 21 Stocks, Including Dow and Home Depot - Insider Monkey |
| 2026-04-24 | — | analyst | The Fly | Intel upgraded, DraftKings downgraded: Wall Street's top analyst calls |
| 2026-04-24 | — | analyst | 24/7 Wall St. | Here Are Friday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Comcast, Draft Kings, IBM, Oracle, Shake Shack, Southwest Airlines, Tesla, and More |
| 2026-04-24 | — | analyst | MT Newswires | Rothschild & Co Redburn Downgrades Insulet to Neutral From Buy, Adjusts PT to $220 From $380 |
| 2026-04-24 | — | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Buys 12,197 Shares of Insulet Corporation $PODD - MarketBeat |
| 2026-04-24 | — | analyst | Benzinga | This Insulet Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga |